211 related articles for article (PubMed ID: 31836708)
21. mTOR-regulated U2af1 tandem exon splicing specifies transcriptome features for translational control.
Chang JW; Yeh HS; Park M; Erber L; Sun J; Cheng S; Bui AM; Fahmi NA; Nasti R; Kuang R; Chen Y; Zhang W; Yong J
Nucleic Acids Res; 2019 Nov; 47(19):10373-10387. PubMed ID: 31504847
[TBL] [Abstract][Full Text] [Related]
22. Clinical and the prognostic characteristics of lung adenocarcinoma patients with ROS1 fusion in comparison with other driver mutations in East Asian populations.
Chen YF; Hsieh MS; Wu SG; Chang YL; Shih JY; Liu YN; Tsai MF; Tsai TH; Yu CJ; Yang JC; Yang PC
J Thorac Oncol; 2014 Aug; 9(8):1171-9. PubMed ID: 25157770
[TBL] [Abstract][Full Text] [Related]
23. CD74-ROS1 fusion transcripts in resected non-small cell lung carcinoma.
Matsuura S; Shinmura K; Kamo T; Igarashi H; Maruyama K; Tajima M; Ogawa H; Tanahashi M; Niwa H; Funai K; Kohno T; Suda T; Sugimura H
Oncol Rep; 2013 Oct; 30(4):1675-80. PubMed ID: 23877438
[TBL] [Abstract][Full Text] [Related]
24. ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular drivers.
Aisner DL; Nguyen TT; Paskulin DD; Le AT; Haney J; Schulte N; Chionh F; Hardingham J; Mariadason J; Tebbutt N; Doebele RC; Weickhardt AJ; Varella-Garcia M
Mol Cancer Res; 2014 Jan; 12(1):111-8. PubMed ID: 24296758
[TBL] [Abstract][Full Text] [Related]
25. Elucidation of the aberrant 3' splice site selection by cancer-associated mutations on the U2AF1.
Yoshida H; Park SY; Sakashita G; Nariai Y; Kuwasako K; Muto Y; Urano T; Obayashi E
Nat Commun; 2020 Sep; 11(1):4744. PubMed ID: 32958768
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion-Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations.
Chen YF; Hsieh MS; Wu SG; Chang YL; Yu CJ; Yang JC; Yang PC; Shih JY
J Thorac Oncol; 2016 Jul; 11(7):1140-52. PubMed ID: 27094798
[TBL] [Abstract][Full Text] [Related]
27. Precision analysis of mutant U2AF1 activity reveals deployment of stress granules in myeloid malignancies.
Biancon G; Joshi P; Zimmer JT; Hunck T; Gao Y; Lessard MD; Courchaine E; Barentine AES; Machyna M; Botti V; Qin A; Gbyli R; Patel A; Song Y; Kiefer L; Viero G; Neuenkirchen N; Lin H; Bewersdorf J; Simon MD; Neugebauer KM; Tebaldi T; Halene S
Mol Cell; 2022 Mar; 82(6):1107-1122.e7. PubMed ID: 35303483
[TBL] [Abstract][Full Text] [Related]
28. ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: a comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features.
Pan Y; Zhang Y; Li Y; Hu H; Wang L; Li H; Wang R; Ye T; Luo X; Zhang Y; Li B; Cai D; Shen L; Sun Y; Chen H
Lung Cancer; 2014 May; 84(2):121-6. PubMed ID: 24629636
[TBL] [Abstract][Full Text] [Related]
29. Skipping of exon 10 in
Shen L; Lei S; Zhang B; Li S; Huang L; Czachor A; Breitzig M; Gao Y; Huang M; Mo X; Zheng Q; Sun H; Wang F
Theranostics; 2020; 10(13):5719-5735. PubMed ID: 32483414
[TBL] [Abstract][Full Text] [Related]
30. Novel deletion of
Dandan S; Yuqin C; Wei L; Ziheng P; Dapeng Z; Jianzhu Y; Xin X; Yonghong L; Fengjun T
J Genet; 2018 Sep; 97(4):939-944. PubMed ID: 30262706
[TBL] [Abstract][Full Text] [Related]
31. 3D culture system containing gellan gum restores oncogene dependence in ROS1 rearrangements non-small cell lung cancer.
Gong B; Oh-Hara T; Fujita N; Katayama R
Biochem Biophys Res Commun; 2018 Jun; 501(2):527-533. PubMed ID: 29738763
[TBL] [Abstract][Full Text] [Related]
32. Alternative splicing of U2AF1 reveals a shared repression mechanism for duplicated exons.
Kralovicova J; Vorechovsky I
Nucleic Acids Res; 2017 Jan; 45(1):417-434. PubMed ID: 27566151
[TBL] [Abstract][Full Text] [Related]
33. RET, ROS1 and ALK fusions in lung cancer.
Takeuchi K; Soda M; Togashi Y; Suzuki R; Sakata S; Hatano S; Asaka R; Hamanaka W; Ninomiya H; Uehara H; Lim Choi Y; Satoh Y; Okumura S; Nakagawa K; Mano H; Ishikawa Y
Nat Med; 2012 Feb; 18(3):378-81. PubMed ID: 22327623
[TBL] [Abstract][Full Text] [Related]
34. AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicing.
Laliotis GI; Chavdoula E; Paraskevopoulou MD; Kaba A; La Ferlita A; Singh S; Anastas V; Nair KA; Orlacchio A; Taraslia V; Vlachos I; Capece M; Hatzigeorgiou A; Palmieri D; Tsatsanis C; Alaimo S; Sehgal L; Carbone DP; Coppola V; Tsichlis PN
Nat Commun; 2021 Jul; 12(1):4624. PubMed ID: 34330897
[TBL] [Abstract][Full Text] [Related]
35. From genotype to phenotype: Are there imaging characteristics associated with lung adenocarcinomas harboring RET and ROS1 rearrangements?
Plodkowski AJ; Drilon A; Halpenny DF; O'Driscoll D; Blair D; Litvak AM; Zheng J; Moskowitz CS; Ginsberg MS
Lung Cancer; 2015 Nov; 90(2):321-5. PubMed ID: 26424208
[TBL] [Abstract][Full Text] [Related]
36. CD74-ROS1 G2032R mutation transcriptionally up-regulates Twist1 in non-small cell lung cancer cells leading to increased migration, invasion, and resistance to crizotinib.
Gou W; Zhou X; Liu Z; Wang L; Shen J; Xu X; Li Z; Zhai X; Zuo D; Wu Y
Cancer Lett; 2018 May; 422():19-28. PubMed ID: 29477381
[TBL] [Abstract][Full Text] [Related]
37. Identification of a Novel RBPMS-ROS1 Fusion in an Adolescent Patient With Microsatellite-instable Advanced Lung Adenocarcinoma Sensitive to Crizotinib: A Case Report.
Zhang Y; Yu M; Yuan M; Chen R; Huang MJ
Clin Lung Cancer; 2020 Mar; 21(2):e78-e83. PubMed ID: 31722815
[No Abstract] [Full Text] [Related]
38. U2af1 is a haplo-essential gene required for hematopoietic cancer cell survival in mice.
Wadugu BA; Nonavinkere Srivatsan S; Heard A; Alberti MO; Ndonwi M; Liu J; Grieb S; Bradley J; Shao J; Ahmed T; Shirai CL; Khanna A; Fei DL; Miller CA; Graubert TA; Walter MJ
J Clin Invest; 2021 Nov; 131(21):. PubMed ID: 34546980
[TBL] [Abstract][Full Text] [Related]
39. Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions.
Suehara Y; Arcila M; Wang L; Hasanovic A; Ang D; Ito T; Kimura Y; Drilon A; Guha U; Rusch V; Kris MG; Zakowski MF; Rizvi N; Khanin R; Ladanyi M
Clin Cancer Res; 2012 Dec; 18(24):6599-608. PubMed ID: 23052255
[TBL] [Abstract][Full Text] [Related]
40. Myelodysplastic neoplasm-associated U2AF1 mutations induce host defense defects by compromising neutrophil chemotaxis.
Gurule NJ; Malcolm KC; Harris C; Knapp JR; O'Connor BP; McClendon J; Janssen WJ; Lee FFY; Price C; Osaghae-Nosa J; Wheeler EA; McMahon CM; Pietras EM; Pollyea DA; Alper S
Leukemia; 2023 Oct; 37(10):2115-2124. PubMed ID: 37591942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
